– MARIO-4, the first eganelisib registration-enabling trial, in front-line metastatic triple negative breast cancer expected to initiate by the end of 2022 – – MARIO-P, a study designed to expand ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) (“Infinity” or the “Company”) today announced its third quarter 2021 financial results and provided a corporate update ...

Infinity Natural valued at $1.3 billion in debut as US energy IPOs rebound Infinity Natural Resources was valued at $1.30 billion after its shares jumped nearly 11% in their NYSE debut on Friday, ...

Dubai, UAE, Arabian Automobiles Company, flagship automotive company of AW Rostamani Group and the exclusive dealer for Infiniti in Dubai and the Northern Emirates, has revealed that it has achieved ...

Infinity IPS is a financial services company. It provides mortgage due diligence and pre-fund and post-close quality control, and additional mortgage services including valuation, risk management, ...